Nephrocare Heal.

Market Cap: N/A
Industry: Healthcare Services
ISIN: INE428V01029
NSEID: NEPHROPLUS
BSEID: 544647

INR

461.80

-9.8 (-2.08%)

BSENSE

Dec 18

BSE+NSE Vol: 16.49 lacs

Click here to access the older version

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 4,685 Cr ()

P/E

69.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Listing of Equity Shares of Nephrocare Health Services Ltd

17-Dec-2025 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from December 17 2025 the Equity Shares of Nephrocare Health Services Ltd (Scrip Code: 544647) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no. 20251216- dated December 16 2025.

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

3.15

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

4.36%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

8.11

EV to EBIT

49.11

EV to EBITDA

27.75

EV to Capital Employed

8.22

EV to Sales

6.12

PEG Ratio

Dividend Yield

ROCE (Latest)

16.74%

ROE (Latest)

11.74%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Nephrocare Heal."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Heal."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Heal."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Nephrocare Heal."
  }
]

Company CV

About Nephrocare Health Services Ltd

Nephrocare Health Services Ltd

Healthcare Services

No Details Available.

Company Coordinates

No Company Details Available